Cefpodoxime 對於耳鼻喉 感染症之臨床試驗

Bacterial infection is one of the most common and important problem in the ENT fields. Antibiotics are often necessary for the treatment and prevention of bacterial infections. Cefpodoxime is a new kind of the 3rd generation cephalosporin. In our trial, the efficacy of cefpodoxime was monitored for its bactericidal effect and clinical improvement. The results showed 84% bacteriological and 80% clinical improvement. No biochemical or hematological deturbance was found in our patients. Regarding efficacy, convenience and safety, we suggest that cefpodoxime is a new choice for the treatment of bacterial infections in the ENT fields. #0117